Barron's Weekend Stock Picks: Nokia, Roku, Nvidia And Moderna's Latest Cancer Treatment Trial

Benzinga reviews this weekend's top stories covered by Barron's. Here are the articles investors need to read.

In "Moderna Reports More Promising Data on Cancer Treatment. The Stock Jumps," Josh Nathan-Kazis writes that Moderna Inc (NASDAQ:MRNA)

shared good news about their cancer treatment trial, suggesting better chances of survival when using their therapy alongside Merck's Keytruda.

Read Next: Nvidia Stock Remains A Bargain Despite More Than Tripling In 2023, Says Bernstein Analyst: 'Cheapest AI Play'

This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Photo: Shutterstock

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.